Flower capsule endoscopy to check stomach contents in healthy people and GLP-1 users
Part of Digestive system clinical trials.
This study tests a new capsule endoscopy method to see how well it finds food still in the stomach. It compares healthy adults with people who take GLP-1 medicines (like for diabetes or weight loss), but only after they have stopped the medicine for 3 months.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You are willing to sign a consent form and follow all study steps.
- You have not taken GLP-1 medicines (like Ozempic, Wegovy) in the last 3 months.
- You do not have diabetes, obesity, or any stomach or swallowing problem.
- You have not had stomach surgery and are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies how a longer fasting period affects stomach contents in people taking GLP-1 receptor agonists (a type of diabetes or weight-loss drug). It helps doctors understand if extra fasting time is needed before an upper endoscopy (a camera test for the stomach).
This trial tests if a capsule-sized camera can be used at home to check for stomach problems. It's for healthy people or those with stomach symptoms like pain, nausea, or bleeding.
This study uses an ultrasound to look at how full your stomach is after taking GLP-1 medications for diabetes or weight loss. It will help doctors understand if current fasting guidelines are safe before surgery or a colonoscopy.
This study will look at how medicines like Ozempic, Wegovy, and Mounjaro affect how well the stomach and intestines move food through the body. It might help find out why these medicines cause digestive problems for some people.
This study looks back at results from a small camera pill (capsule endoscopy) used to find the source of bleeding in the digestive tract. It may help doctors better understand how well this test works for people with gastrointestinal bleeding.
This study tests a new oral capsule that delivers a medicine called PG-102, which is a dual GLP-1/2 agonist (similar to drugs used for diabetes and weight loss). It is for healthy volunteers to see how the body handles the medicine. The study has two parts: one for people with a lower BMI and one for people with a higher BMI (over 30).
Hear when a new Endoscopy, Digestive System trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.